It is a healthcare private limited company based in Jaipur, Rajasthan, India, established in 2019.
2019 | Jaipur, Rajasthan, India | ActiveFranko - India - Drugs Formulations Private Limited, a active private limited company, was established on 21 February 2019 in Jaipur, Rajasthan, India. Engaging in medical & laboratory equipment within the trade sector, it holds CIN: U24299RJ2019PTC064070. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Manisha Goyal (Director), Saurabh Agarwal (Director). Past directors included Brij Mohan Goyal. It holds ₹1.50 M open charges and no settled loans. Its latest AGM occurred on 18 September 2025, with the balance sheet filed on 31 March 2025. It is based at 268,Patel Nagar F 1 Mansarovar, Jaipur, Rajasthan, 302020.
U24299RJ2019PTC064070
064070
21 February 2019
₹0.10 M
₹0.10 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Franko - India - Drugs Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manisha Goyal | Director | 15 Nov 2019 | Current |
| Saurabh Agarwal | Director | 21 Feb 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Franko - India - Drugs Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 241.84% increase. The company also saw a substantial improvement in profitability, with a 204.83% increase in profit. The company's net worth Soared by an impressive increase of 399.8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Franko - India - Drugs Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2022 | Hdfc Bank Limited | ₹1.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Franko - India - Drugs Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Franko - India - Drugs Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Franko - India - Drugs Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Franko - India - Drugs Formulations Private Limited last Annual general meeting of members was held on 18 Sep 2025 as per latest MCA records. was completed.
Progress on Franko - India - Drugs Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.50 M with Charge ID 100658783 was registered on 31 Oct 2022. was documented.
Progress on Manisha Goyal was appointed as a Director was appointed as a Director on 15 Nov 2019 & has been associated with this company since 6 years 15 days . was documented.
Saurabh Agarwal was appointed as a Director was appointed as a Director on 21 Feb 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
Franko - India - Drugs Formulations Private Limited was registered on 21 Feb 2019 with Roc Jaipur & aged 6 years 9 months as per MCA records. was recorded as a recent event.
The CIN of Franko - India - Drugs Formulations Private Limited is U24299RJ2019PTC064070.
Franko - India - Drugs Formulations Private Limited is headquartered at 268,Patel Nagar F 1 Mansarovar, Jaipur, Rajasthan, 302020.
Franko - India - Drugs Formulations Private Limited was incorporated on 21 February 2019.
The current directors of Franko - India - Drugs Formulations Private Limited are
The primary industry of Franko - India - Drugs Formulations Private Limited is Trade.
Franko - India - Drugs Formulations Private Limited is unlisted.
The authorized capital of Franko - India - Drugs Formulations Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Franko - India - Drugs Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX